Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity

Area of Science:

• Neuroscience
• Neuroinflammation
• Cellular Biology

Background:

• Peripheral benzodiazepine receptor (PBR) is a known marker for inflammation and gliosis in brain injury.
• Previous research indicated PBR expression is specific to activated microglia and macrophages in injured brain tissue.

Purpose of the Study:

• To investigate the cellular and subcellular distribution of PBR in the hippocampus following neurotoxic injury.
• To determine if astrocytes, in addition to microglia, express PBR after brain injury.

Main Methods:

• Hippocampal lesions were induced using the neurotoxicant trimethyltin (TMT).
• Cellular responses were assessed using silver staining for neuronal degeneration, immunohistochemistry for glial markers (microglia and astrocytes), and PBR fluorescence.
• [3H]PK11195 microautoradiography was employed to visualize PBR.
• Double labeling techniques were used to co-localize PBR with microglial and astrocyte markers.

Main Results:

• TMT exposure caused neuronal degeneration, microgliosis, and astrocytosis in the hippocampus.
• Both microglia and astrocytes were found to express high levels of PBR following TMT-induced injury.
• PBR expression was confirmed in both cell types using double labeling with specific markers.
• The study provides the first evidence of in situ nuclear localization of PBR within glial cells.

Conclusions:

• Peripheral benzodiazepine receptor (PBR) expression is not exclusive to microglia and macrophages but is also significantly upregulated in astrocytes after brain injury.
• These findings expand our understanding of PBR's role in neuroinflammation and suggest it is a marker for both microglial and astroglial activation.
• The discovery of nuclear PBR localization in glial cells opens new avenues for research into its intracellular functions.